Merck "Parallel" R&D: Internal Programs Match External To Limit Uncertainty

Merck's practice of maintaining an internal research program parallel to any third-party collaboration guarantees an R&D project's survival should the external venture lose its funding, Merck Research Labs President Edward Scolnick, PhD, said.

More from Archive

More from Pink Sheet